KYLE GEORGE: Open Payments
NPI 1225220643 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,962 in 93 payments from 11 companies in 2025. Trend: 2023 $1,201 · 2024 $7,902 · 2025 $3,962
Food & beverage: $2,387Consulting: $1,420Education: $155
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 4 | $1,578 |
| Amgen Inc. | 41 | $733 |
| UCB, Inc. | 10 | $531 |
| ABBVIE INC. | 18 | $430 |
| Janssen Biotech, Inc. | 9 | $293 |
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| Janssen Scientific Affairs, LLC | 2 | $128 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Lilly USA, LLC | 1 | $30 |
| PFIZER INC. | 2 | $30 |
Products named: ACTHAR, Bimzelx, TREMFYA, OTEZLA, RINVOQ, TAVNEOS, SKYRIZI, SAPHNELO.
Industry payments across ID — which companies pay providers there.
